Cue Biopharma
36 hedge funds and large institutions have $15.2M invested in Cue Biopharma in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 3 closing their positions.
Holders
36
Holders Change
-1
Holders Change %
-2.7%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
14
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
JPMorgan Chase & Co
New York
| $21K | +$1.96K | +422 | +10% |
|
|
DOA
27
D'Orazio & Associates
Falls Church,
Virginia
| $19K | -$19K | -4,000 | -50% |
|
28
New York State Common Retirement Fund
Albany,
New York
| $15K | -$80.3K | -16,600 | -84% |
|
29
Legal & General Group
London,
United Kingdom
| $12K | – | – | – |
|
|
SO
30
STRS Ohio
Columbus,
Ohio
| $11K | – | – | – |
|
|
AIP
31
Ameritas Investment Partners
Lincoln,
Nebraska
| $7K | – | – | – |
|
|
MAM
32
Meeder Asset Management
Dublin,
Ohio
| $4K | -$4.13K | -934 | -51% |
|
33
Bank of Montreal
Toronto,
Ontario, Canada
| $4K | +$3.44K | +752 | +616% |
|
34
BNP Paribas Financial Markets
Paris,
France
| $1.42K | -$1.25K | -266 | -47% |
|
|
LTFS
35
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
PAWC
36
P.A.W. Capital
Greenwich,
Connecticut
| – | -$724K | -80,000 | Closed |
|
37
Barclays
London,
United Kingdom
| – | -$60K | -6,628 | Closed |
|
38
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$26K | -2,808 | Closed |
|